Nurse Practitioner Program year 2024 Reported 2022–2024 Source: CMS Open Payments, 2026 publication

Alison Buck

Nurse Practitioner Savannah, GA Nurse Practitioner

NPI 1821498338 CMS profile 10831633

210 E Derenne Ave, Savannah, GA 31405

Open in the dashboard

General payments

$2,363

53 records reported · program years 2022–2024

Research payments

$0

Paid to them · None reported · program years 2022–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Alison Buck of Savannah, GA is reported in the CMS Open Payments database as having received $2,363 across 53 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 83rd percentile of Nurse Practitioner profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $690 19
2023 General $942 24
2022 General $731 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alison Buck
  • Nurse Practitioner median
  • Middle half of Nurse Practitioner
  • National median

In program year 2025, general payments to Alison Buck were reported at $0. Among 41,044 Nurse Practitioner profiles paid that year, the median was $174 and the middle half received between $55 and $557.

Show as a table
Year Alison Buck Nurse Practitioner median Middle half National median
2019 $0 $50 $22–$97 $163
2020 $0 $40 $16–$108 $114
2021 $0 $135 $40–$426 $132
2022 $731 $152 $48–$470 $149
2023 $942 $166 $54–$529 $160
2024 $690 $173 $55–$556 $164
2025 $0 $174 $55–$557 $169

Breakdown

Who paid General payments · program years 2022–2024
  1. Boston Scientific Corporation $2,213 46 payments
  2. Abbott Laboratories $87 4 payments
  3. NuVasive, Inc. $39 2 payments
  4. Nevro Corp. $24 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2024
  1. Food and Beverage $2,363 53 payments
Products named General payments · program years 2022–2024
  1. WaveWriter Alpha Prime 16 $2,052 37 payments
  2. PROCLAIM $87 4 payments
  3. General - Pain Management $38 3 payments
  4. Senza $24 1 payment
  5. Simplify Cervical Artificial Disc $18 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

277

Median for Nurse Practitioner: 389

Drug cost

$2,143

Median for Nurse Practitioner: $21,885

Branded share of claims

0%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Tizanidine Hcl Generic 83 $1,100
Diclofenac Sodium Generic 59 $548
Methylprednisolone Generic 28 $165
Cyclobenzaprine Hcl Generic 17 $158
Meloxicam Generic 63 $100
Tramadol Hcl Generic 27 $72

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 28 billing codes

Paid by Medicare

$16,505

Of which drugs: $50

Medicare patients

180

Average age 73

Services billed

428

110 women, 70 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 73%
Diabetes 30%
Chronic kidney disease 24%
Ischemic heart disease 23%
Depression 21%
COPD 19%
Cancer 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 13 65 $50

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

53 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record